Key terms
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PFE news
Today
4:10pm ET
Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)
Today
7:38am ET
Pfizer Exceeds Q1 Expectations with Strong Earnings and Raises 2024 Guidance: A Buy Rating by Evan Seigerman
Today
6:32am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)
Today
5:20am ET
Pfizer’s Mixed Financial Signals: A Delicate Balance Between Growth and Uncertainty
Today
3:50am ET
Pfizer (PFE) Receives a Hold from Barclays
Today
1:15am ET
Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings
Yesterday
4:35pm ET
Jefferies Remains a Buy on Pfizer (PFE)
Yesterday
9:44am ET
PFE Earnings: Pfizer Rises on Smashing Q1 Estimates
Yesterday
9:05am ET
UBS Reaffirms Their Hold Rating on Pfizer (PFE)
Yesterday
9:05am ET
Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)
Yesterday
7:05am ET
Options Volatility and Implied Earnings Moves Today, May 01, 2024
Yesterday
6:47am ET
Pfizer raises FY24 adjusted EPS view to $2.15-$2.35 from $2.05-$2.25
Yesterday
6:45am ET
Pfizer reports Q1 adjusted EPS 82c, consensus 52c
Yesterday
6:23am ET
Pfizer developing online platform to sell drugs directly to consumer, FT says
Apr 30
8:25pm ET
Notable companies reporting before tomorrow’s open
Apr 30
1:39pm ET
Notable companies reporting before tomorrow’s open
Apr 30
12:45pm ET
Pfizer call volume above normal and directionally bullish
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 29
6:44pm ET
Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer
Apr 29
7:03am ET
Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay
Apr 26
12:33pm ET
Pfizer (NYSE:PFE) Notches Up on New FDA Approval
Apr 26
6:48am ET
Pfizer announces approval of BEQVE by FDA for adults with hemophilia B
Apr 25
10:25am ET
Pfizer call volume above normal and directionally bullish
Apr 23
5:32am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
Apr 22
8:13am ET
Pfizer announces EC approval for Emblaveo
Apr 15
2:26pm ET
Pfizer call volume above normal and directionally bullish
Apr 15
12:50pm ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
11:49am ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
11:49am ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
7:40am ET
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)
Apr 15
5:48am ET
Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push
No recent press releases are available for PFE
PFE Financials
Key terms
Ad Feedback
PFE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PFE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
